Results 241 to 250 of about 226,969 (309)
Real-World Study Assessing Characteristics and Treatment Patterns of Patients With Human Epidermal Growth Factor Receptor 2 Immunohistochemistry 0 and Human Epidermal Growth Factor Receptor 2-Low Stage IV Breast Cancer: A Multicenter Retrospective Study. [PDF]
JCO Precis OncolTan CJ +12 more
europepmc +1 more source
[Gefitinib (Iressa). Laboratory: AstraZeneca].
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2003 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New Scientist, 2021
Widely used in the UK, the Oxford/AstraZeneca vaccine is effective at preventing deaths and ...
openaire +1 more source
Widely used in the UK, the Oxford/AstraZeneca vaccine is effective at preventing deaths and ...
openaire +1 more source
European J. of International Management, 2019
The Pfizer-AstraZeneca case shows how an acquisition target can successfully repel an attempted takeover by engaging with positively disposed stakeholders and managing communications and the news agenda. The company communicated clearly, consistently and powerfully throughout the process and could benefit from a natural, if temporary, coalition of ...
Asja Hot +3 more
openaire +1 more source
The Pfizer-AstraZeneca case shows how an acquisition target can successfully repel an attempted takeover by engaging with positively disposed stakeholders and managing communications and the news agenda. The company communicated clearly, consistently and powerfully throughout the process and could benefit from a natural, if temporary, coalition of ...
Asja Hot +3 more
openaire +1 more source
Chemical & Engineering News Archive, 2013
The bicycle-filled city of Cambridge, England, has been closely tied to biotechnology since 1953, when Francis H. C. Crick and James D. Watson discovered the structure of DNA in the University of Cambridge’s Cavendish building. Other luminaries that once studied at the university include Isaac Newton and Charles Darwin.
openaire +1 more source
The bicycle-filled city of Cambridge, England, has been closely tied to biotechnology since 1953, when Francis H. C. Crick and James D. Watson discovered the structure of DNA in the University of Cambridge’s Cavendish building. Other luminaries that once studied at the university include Isaac Newton and Charles Darwin.
openaire +1 more source
Financial Analysis of AstraZeneca
SSRN Electronic Journal, 2021The business under our conversation is AstraZeneca Oxford is a British global pharma industry, it was established in April 1999, the settlement is in Cambridge, UK. It is the Pharma fabricating industry that produces distinctive live-saving medications to the world. They work on medication for the treatment of oncology and Biopharmaceuticals.
Khuloud Al Ghanem +6 more
openaire +1 more source
IDrugs : the investigational drugs journal, 2003
NO-naproxen, consisting of the NSAID naproxen linked to a nitric oxide (NO) moiety, is under development by AstraZeneca plc, under license from NicOx SA, for the potential treatment of acute/chronic pain.
openaire +2 more sources
NO-naproxen, consisting of the NSAID naproxen linked to a nitric oxide (NO) moiety, is under development by AstraZeneca plc, under license from NicOx SA, for the potential treatment of acute/chronic pain.
openaire +2 more sources
IDrugs : the investigational drugs journal, 2004
AstraZeneca is developing ZD-6126, one of the ANG-400 series of vascular-targeting and tubulin-binding agents under license from Angiogene Pharmaceuticals Ltd, for the potential treatment of cancer.
Jens, Soltau, Joachim, Drevs
openaire +1 more source
AstraZeneca is developing ZD-6126, one of the ANG-400 series of vascular-targeting and tubulin-binding agents under license from Angiogene Pharmaceuticals Ltd, for the potential treatment of cancer.
Jens, Soltau, Joachim, Drevs
openaire +1 more source
Current opinion in investigational drugs (London, England : 2000), 2002
Fulvestrant (Faslodex) is an estrogen receptor (ER) downregulator under development by AstraZeneca for the potential treatment of breast cancer [172191], [237518], [314472], [349551]. In March 2001, an NDA was filed in the US for the second-line treatment of advanced breast cancer in postmenopausal women who have progressed on prior hormonal therapy ...
openaire +1 more source
Fulvestrant (Faslodex) is an estrogen receptor (ER) downregulator under development by AstraZeneca for the potential treatment of breast cancer [172191], [237518], [314472], [349551]. In March 2001, an NDA was filed in the US for the second-line treatment of advanced breast cancer in postmenopausal women who have progressed on prior hormonal therapy ...
openaire +1 more source